Urology Diagnostics Sales Exec — Prolaris & MyRisk (GA)

Myriad Genetics Inc.; Salt Lake City (UT); Vor Ort; USD 182.000 - 207.000; Vollzeit

Benefits dieser Stelle

Health and Wellness

DTO policy (unlimited)

401(k) with employer match

Student debt repayment

Stock program

MOTUS car stipend

Mileage reimbursement

Zusammenfassung

Myriad Urology in Salt Lake City seeks an Account Executive to grow the Prolaris, MyRisk, and Precise portfolio with hospital systems, large urology group practices, and private practices focusing on urologists and radiation oncologists.

You will collaborate with cross-functional teams to advance AI-enabled diagnostics and digital pathology analytics, supporting precision oncology and improved patient outcomes.

Qualifikationen

• BS/BA degree preferred and minimum of 3+ years of sales experience in medical devices, pharmaceuticals, or related healthcare services.
• Experience in urology/urologic oncology is preferred.
• Strong work ethic, self-motivation, independence, and professional discretion.

Aufgaben

• Achieve sales targets for Prolaris, MyRisk, and Precise by meeting or exceeding objectives.
• Develop and execute plans to increase test orders and market share.
• Engage with urologists, urologic oncologists, pathologists, and radiation oncologists across settings.
• Educate providers to improve patient access to testing and grow weekly orders.
• Advise physicians on precision oncology approaches aligned with cancer care.
• Build two-way relationships and understand practice economics and value drivers.

Kenntnisse

Sales experience

Urology knowledge

Ausbildung

Bachelor's degree

Jobbeschreibung

Myriad Urology in Salt Lake City seeks an Account Executive to grow the Prolaris, MyRisk, and Precise portfolio with hospital systems, large urology group practices, and private practices focusing on urologists and radiation oncologists.

You will collaborate with cross-functional teams to advance AI-enabled diagnostics and digital pathology analytics, supporting precision oncology and improved patient outcomes.